University of California, San Francisco: HIV Infections trials
The registry lists 72 HIV Infections studies with University of California, San Francisco as lead sponsor. 5 are open to participants now and 25 have results posted.
Phase 1 5Phase 2 6Phase 3 4Phase 4 9No phase 50(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Feasibility of HPV Testing With Mail-delivered Sample Collection KitsRecruitingNCT07087145
- Innovative Administration of Long-Acting Injectables for HIV Treatment Enhancement at HomeEnrolling by invitationNCT06488846
- Text Education About Cardiovascular Health and HIV (TEACH-HIV)RecruitingNCT05642858Not applicable
- Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant TuberculosisRecruitingNCT05553236Not applicable
- SCOPE: Observational Study of the Consequences of the Protease Inhibitor EraRecruitingNCT00187512
- Heart Failure Polypill at a Safety Net HospitalCompletedNCT06029712Phase 2Results posted
- Enhanced Virologic Monitoring for Pregnant and Postpartum Women With HIVCompletedNCT05845619Not applicableResults posted
- Youth Ending the HIV EpidemicCompletedNCT05789875Not applicableResults posted
- AmbassADDOrs for Health StudyTerminatedNCT05357144Not applicableResults posted
- Phase 2 Trial of LACTIN-V in Women at High Risk of HIV AcquisitionCompletedNCT05022212Phase 2Results posted
- Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in MenCompletedNCT04772469Not applicableResults posted
- HIV Prevention Peer Navigation for Justice Involved WomenCompletedNCT04680390Not applicableResults posted
- Dihydroartemisinin-Piperaquine in the Context of Antiretroviral TherapyCompletedNCT04487145Phase 4Results posted
- Thermocoagulation for Treatment of Precancerous Cervical LesionsCompletedNCT04191967Not applicableResults posted
- Options for Delivering Isoniazid-Rifapentine (3HP) for TB Prevention (3HP Options Implementation Trial)CompletedNCT03934931Not applicableResults posted
- Mobile Technology to Extend Clinic-based Counseling for HIV+s in UgandaCompletedNCT03928418Not applicableResults posted
- Immunologic Response to Kansui in Treated HIV+ Individuals: a Dose Escalation StudyTerminatedNCT02531295Phase 1Results posted
- Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2)CompletedNCT02282293Phase 3Results posted
- Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation StudyCompletedNCT01944371Phase 1/2Results posted
- Mesalamine to Reduce T Cell Activation in HIV InfectionCompletedNCT01090102Phase 4Results posted
- HIV Persistence and Viral ReservoirsCompletedNCT01025427Phase 4Results posted
- Pilot Study on the Effect of Adding Raltegravir +/- a Second Drug on HIV Levels in the GutCompletedNCT00884793Not applicableResults posted
- Treatment of Acute Hepatitis C Virus in HIV Co-InfectionCompletedNCT00845676Phase 4Results posted
- Effect of Maraviroc on Endothelial Function in HIV-Infected PatientsCompletedNCT00844519Phase 3Results posted
- Effect of Raltegravir on Endothelial Function in HIV-Infected PatientsCompletedNCT00843713Phase 4Results posted
- Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic FailureCompletedNCT00735072Phase 4Results posted
- Raltegravir Augmentation on Persistent Central Nervous System (CNS) Immunoactivation in Treated HIV-1 PatientsCompletedNCT00672932Not applicableResults posted
- Raltegravir Intensification in HIV-infected PatientsCompletedNCT00631449Phase 4Results posted
- HIV Testing Strategies in the Perinatal SettingCompletedNCT00503308Not applicableResults posted
- Valganciclovir to Reduce T Cell Activation in HIV InfectionCompletedNCT00264290Phase 4Results posted
- A Pilot Study of an Online HIV Stigma Training for Nursing Students in IranWithdrawnNCT06509113Not applicable
- People Living With HIV, Oral and Oropharyngeal Cancer, and Health EquityActive, not recruitingNCT06055868
- Screening Algorithms for Cervical and Anal High-Grade Squamous Intraepithelial Lesions in People With HIV in Mexico and Puerto RicoActive, not recruitingNCT05074264Not applicable
- Improving Health Outcomes for Women Living With HIVCompletedNCT03525340Not applicable
- Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)CompletedNCT03207945Phase 3
- Changing Health Through Food Support (CHEFS) ProgramCompletedNCT03191253Not applicable
- Gene Expression Outcomes in Interventions for Substance Using HIV+ Minority MenCompletedNCT03143205Not applicable
- Development of a Couple-Based Mobile Health Intervention for Enhancing HIV Care Engagement Outcomes (N'Gage)CompletedNCT03100643
- Improving Engagement in HIV Care for High-risk WomenCompletedNCT03081559Not applicable
- The Impact and Cost-effectiveness of Safer Conception Strategies for HIV-discordant Couples (SAFER)CompletedNCT03049176
- Duo Partnership Adherence Commitment TherapyCompletedNCT02925949Not applicable
- Innovative Behavioral Economics Incentives Strategies for HealthCompletedNCT02890459Not applicable
- Evaluation of Conditional Cash Transfers to Increase Retention in PMTCT Services in Akwa Ibom State, NigeriaCompletedNCT02447159Not applicable
- DuoPACT Pilot InterventionCompletedNCT02181881Not applicable
- RCT of an Integrative Intervention for Non-Treatment-Seeking Meth UsersCompletedNCT01926184Not applicable
- Primary Care-Based Interventions to Reduce Alcohol Use Among HIV PatientsCompletedNCT01671501Not applicable
- Inflammation, Viral Replication, and Atherosclerosis in Treated HIV InfectionCompletedNCT01519141
- Project RAP: Family-based HIV Prevention in the Juvenile Drug CourtCompletedNCT01403298Not applicable
- The Role of Inflammation and Aging in HIV-Associated Cardiovascular RiskCompletedNCT01333644
- A Randomized Controlled Trial of the Bruthas ProjectCompletedNCT01270230Phase 2
- Pharmacokinetic Interactions Between an Herbal Medicine (African Potato) and Antiretroviral Agents (Lopinavir/Ritonavir)CompletedNCT01227590Phase 1
- Improving Sleep and Quality of Life in Adults With HIV DiseaseCompletedNCT01073423Not applicable
- Adherence-Suppression-Resistance Relationships for Atripla Compared to Historical Antiretroviral RegimensCompletedNCT01006005
- Integrating Family Planning Services Into HIV Care and Treatment in Nyanza Province, KenyaCompletedNCT01001507Not applicable
- Trial Embedded in an Electronic Personal Medical Health RecordsCompletedNCT00972348Not applicable
- Integration of HIV Care and Treatment Into Antenatal Care in Migori District, KenyaCompletedNCT00931216Not applicable
- Interaction of Alcohol and Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS and HIV/AIDS With Hepatitis C Virus (HCV) Co-InfectionCompletedNCT00879047Phase 1
- Epidemiology and Pathogenesis of HIV-Associated Pulmonary HypertensionCompletedNCT00845013
- Intervention for (Those) Recently Informed of Seropositive Status (IRISS)CompletedNCT00720733Not applicable
- Pharmacokinetics of Raltegravir During Third Trimester Pregnancy and Post-PartumWithdrawnNCT00689910
- Effectiveness of Coping Training for People With HIV Experiencing Treatment Side Effects (The Balance Project)CompletedNCT00643903Not applicable
- Role of Positive Affect in Adjustment to HIVCompletedNCT00582023
- Biomarkers of Insomnia and Fatigue in HIV/AIDS (Symptoms and Genetics Study)CompletedNCT00503633
- Behavioral, Clinical and Basic Science Studies of Non-occupational Post-exposure Prophylaxis ("PEP-2")CompletedNCT00473018Not applicable
- Effectiveness of Structured Ecosystems Therapy for Reducing HIV Risk Behaviors and Improving Treatment Adherence in HIV Infected Men Released From PrisonCompletedNCT00344591Phase 2
- A Mindfulness Based Approach to HIV Treatment Side EffectsCompletedNCT00312936Phase 1/2
- The Efficacy of the HIV/AIDS Symptom Management ManualCompletedNCT00241202Not applicable
- Specialized Cognitive-Behavioral Counseling Intervention to Reduce HIV Transmission Risk Behavior in HIV-Infected MenCompletedNCT00218712Not applicable
- Pre-HIV Test Counseling Intervention to Reduce HIV Infection Risk Behavior in Men Who Are Not HIV InfectedCompletedNCT00218699Not applicable
- Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide ResistanceCompletedNCT00187551Phase 4
- Effectiveness of the Diaphragm for HIV PreventionWithdrawnNCT00121459Phase 3
- Evaluation of the Epidermal Langerhans Cell Population in AIDS / ARC Patients by the Topical Application of a Potent Contact Allergen (1-Chloro-2,4-Dinitro-Chlorobenzene) (DNCB)CompletedNCT00002031Not applicable